

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protoporphyrinogen IX metabolic process (GO:0046501) | 8.72716737 |
| 2 | protoporphyrinogen IX biosynthetic process (GO:0006782) | 7.73195315 |
| 3 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.07372451 |
| 4 | porphyrin-containing compound biosynthetic process (GO:0006779) | 5.88346730 |
| 5 | negative regulation of cell killing (GO:0031342) | 5.83264091 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 5.83264091 |
| 7 | regulation of B cell receptor signaling pathway (GO:0050855) | 5.71888421 |
| 8 | regulation of gamma-delta T cell differentiation (GO:0045586) | 5.30367573 |
| 9 | tetrapyrrole biosynthetic process (GO:0033014) | 5.19710313 |
| 10 | regulation of gamma-delta T cell activation (GO:0046643) | 5.04683092 |
| 11 | heme biosynthetic process (GO:0006783) | 5.02135650 |
| 12 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 4.95825723 |
| 13 | microglial cell activation (GO:0001774) | 4.88982896 |
| 14 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.85099822 |
| 15 | negative T cell selection (GO:0043383) | 4.80986797 |
| 16 | hepatocyte apoptotic process (GO:0097284) | 4.79563443 |
| 17 | positive T cell selection (GO:0043368) | 4.78927491 |
| 18 | hemoglobin metabolic process (GO:0020027) | 4.78290334 |
| 19 | porphyrin-containing compound metabolic process (GO:0006778) | 4.70280180 |
| 20 | negative thymic T cell selection (GO:0045060) | 4.69174723 |
| 21 | positive thymic T cell selection (GO:0045059) | 4.63022231 |
| 22 | positive regulation of granulocyte differentiation (GO:0030854) | 4.57329085 |
| 23 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 4.51474176 |
| 24 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 4.51474176 |
| 25 | modulation by symbiont of host immune response (GO:0052553) | 4.51474176 |
| 26 | positive regulation by symbiont of host defense response (GO:0052509) | 4.51474176 |
| 27 | modulation by symbiont of host defense response (GO:0052031) | 4.51474176 |
| 28 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 4.51474176 |
| 29 | negative regulation of amyloid precursor protein catabolic process (GO:1902992) | 4.50796729 |
| 30 | erythrocyte maturation (GO:0043249) | 4.34716363 |
| 31 | lysine catabolic process (GO:0006554) | 4.31964779 |
| 32 | lysine metabolic process (GO:0006553) | 4.31964779 |
| 33 | detection of molecule of bacterial origin (GO:0032490) | 4.28747126 |
| 34 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.18642470 |
| 35 | B cell receptor signaling pathway (GO:0050853) | 4.12049935 |
| 36 | negative regulation of T cell mediated immunity (GO:0002710) | 4.07305280 |
| 37 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 4.05562726 |
| 38 | phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092) | 4.04036307 |
| 39 | cysteine metabolic process (GO:0006534) | 3.97714652 |
| 40 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 3.97377692 |
| 41 | heme metabolic process (GO:0042168) | 3.92271370 |
| 42 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.92238212 |
| 43 | plasma lipoprotein particle assembly (GO:0034377) | 3.87906764 |
| 44 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.75503301 |
| 45 | T cell selection (GO:0045058) | 3.72057274 |
| 46 | cellular extravasation (GO:0045123) | 3.65262745 |
| 47 | regulation of cholesterol homeostasis (GO:2000188) | 3.64065897 |
| 48 | macrophage activation involved in immune response (GO:0002281) | 3.60971577 |
| 49 | neutrophil mediated immunity (GO:0002446) | 3.57623751 |
| 50 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.57109696 |
| 51 | response to interleukin-15 (GO:0070672) | 3.56847127 |
| 52 | macrophage activation (GO:0042116) | 3.55719871 |
| 53 | protein-lipid complex assembly (GO:0065005) | 3.55505158 |
| 54 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.54205383 |
| 55 | regulation of necroptotic process (GO:0060544) | 3.53338333 |
| 56 | thymic T cell selection (GO:0045061) | 3.52537678 |
| 57 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 3.51308581 |
| 58 | positive regulation of B cell differentiation (GO:0045579) | 3.51009833 |
| 59 | negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642) | 3.50885440 |
| 60 | regulation of B cell differentiation (GO:0045577) | 3.50455166 |
| 61 | rhodopsin mediated signaling pathway (GO:0016056) | 3.50026754 |
| 62 | retinal cone cell development (GO:0046549) | 3.48890952 |
| 63 | myeloid leukocyte mediated immunity (GO:0002444) | 3.43651050 |
| 64 | detection of external biotic stimulus (GO:0098581) | 3.39722509 |
| 65 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.39058102 |
| 66 | histone H3-K4 trimethylation (GO:0080182) | 3.38321049 |
| 67 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.36847984 |
| 68 | activated T cell proliferation (GO:0050798) | 3.34526314 |
| 69 | alpha-linolenic acid metabolic process (GO:0036109) | 3.33947480 |
| 70 | pre-miRNA processing (GO:0031054) | 3.33666855 |
| 71 | histone mRNA catabolic process (GO:0071044) | 3.33400737 |
| 72 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.32159085 |
| 73 | kynurenine metabolic process (GO:0070189) | 3.31888433 |
| 74 | sulfur amino acid catabolic process (GO:0000098) | 3.30607108 |
| 75 | glyoxylate metabolic process (GO:0046487) | 3.30253755 |
| 76 | detection of other organism (GO:0098543) | 3.26805509 |
| 77 | negative regulation of fatty acid biosynthetic process (GO:0045717) | 3.26615427 |
| 78 | photoreceptor cell development (GO:0042461) | 3.24947342 |
| 79 | dosage compensation (GO:0007549) | 3.21887497 |
| 80 | oxygen transport (GO:0015671) | 3.21883231 |
| 81 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.20620565 |
| 82 | T cell migration (GO:0072678) | 3.20275278 |
| 83 | regulation of beta-amyloid formation (GO:1902003) | 3.18049146 |
| 84 | nuclear pore complex assembly (GO:0051292) | 3.17319663 |
| 85 | L-phenylalanine catabolic process (GO:0006559) | 3.17183111 |
| 86 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 3.17183111 |
| 87 | L-phenylalanine metabolic process (GO:0006558) | 3.16493708 |
| 88 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.16493708 |
| 89 | response to methylmercury (GO:0051597) | 3.14258569 |
| 90 | erythrocyte development (GO:0048821) | 3.14241394 |
| 91 | regulation of RNA export from nucleus (GO:0046831) | 3.12750023 |
| 92 | serine family amino acid catabolic process (GO:0009071) | 3.12638100 |
| 93 | myeloid cell development (GO:0061515) | 3.12618955 |
| 94 | negative regulation of B cell proliferation (GO:0030889) | 3.12022798 |
| 95 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.11232582 |
| 96 | response to host immune response (GO:0052572) | 3.11232582 |
| 97 | urea metabolic process (GO:0019627) | 3.10640543 |
| 98 | urea cycle (GO:0000050) | 3.10640543 |
| 99 | regulation of granulocyte differentiation (GO:0030852) | 3.09391746 |
| 100 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.09369560 |
| 101 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.09003290 |
| 102 | monoubiquitinated protein deubiquitination (GO:0035520) | 3.07560719 |
| 103 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 3.06713970 |
| 104 | 2-oxoglutarate metabolic process (GO:0006103) | 3.05317708 |
| 105 | leukocyte aggregation (GO:0070486) | 3.05032967 |
| 106 | positive regulation of cellular response to oxidative stress (GO:1900409) | 3.04413254 |
| 107 | positive regulation of response to oxidative stress (GO:1902884) | 3.04413254 |
| 108 | retinal rod cell development (GO:0046548) | 3.04210558 |
| 109 | eye photoreceptor cell development (GO:0042462) | 3.02447713 |
| 110 | protein K11-linked deubiquitination (GO:0035871) | 3.01527571 |
| 111 | neutrophil activation involved in immune response (GO:0002283) | 3.00928799 |
| 112 | megakaryocyte development (GO:0035855) | 3.00849912 |
| 113 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.00006890 |
| 114 | aromatic amino acid family catabolic process (GO:0009074) | 2.97761501 |
| 115 | erythrocyte differentiation (GO:0030218) | 2.96996321 |
| 116 | positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110 | 2.95672516 |
| 117 | mitochondrial outer membrane permeabilization involved in programmed cell death (GO:1902686) | 2.95672516 |
| 118 | positive regulation of histone deacetylation (GO:0031065) | 2.94325468 |
| 119 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.93950843 |
| 120 | negative regulation of interleukin-12 production (GO:0032695) | 2.93554690 |
| 121 | cellular response to interleukin-15 (GO:0071350) | 2.92732014 |
| 122 | detection of biotic stimulus (GO:0009595) | 2.92518430 |
| 123 | protein K48-linked deubiquitination (GO:0071108) | 2.90604415 |
| 124 | proline biosynthetic process (GO:0006561) | 2.90598864 |
| 125 | tetrapyrrole metabolic process (GO:0033013) | 2.89618266 |
| 126 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.89618002 |
| 127 | response to host (GO:0075136) | 2.89086518 |
| 128 | response to host defenses (GO:0052200) | 2.89086518 |
| 129 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 2.89086518 |
| 130 | indole-containing compound catabolic process (GO:0042436) | 2.88679690 |
| 131 | indolalkylamine catabolic process (GO:0046218) | 2.88679690 |
| 132 | tryptophan catabolic process (GO:0006569) | 2.88679690 |
| 133 | photoreceptor cell maintenance (GO:0045494) | 2.88607838 |
| 134 | regulation of alpha-beta T cell proliferation (GO:0046640) | 2.88585294 |
| 135 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.87858163 |
| 136 | regulation of sister chromatid cohesion (GO:0007063) | 2.87577802 |
| 137 | positive regulation of receptor recycling (GO:0001921) | 2.86643947 |
| 138 | embryonic process involved in female pregnancy (GO:0060136) | 2.86406896 |
| 139 | negative regulation of adaptive immune response (GO:0002820) | 2.86327747 |
| 140 | response to lead ion (GO:0010288) | 2.86195721 |
| 141 | myeloid cell activation involved in immune response (GO:0002275) | 2.86157301 |
| 142 | positive regulation of insulin receptor signaling pathway (GO:0046628) | 2.85521480 |
| 143 | cytoplasmic mRNA processing body assembly (GO:0033962) | 2.83607426 |
| 144 | regulation of clathrin-mediated endocytosis (GO:2000369) | 2.82903898 |
| 145 | Peyers patch development (GO:0048541) | 2.82770590 |
| 146 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.82770590 |
| 147 | histone lysine demethylation (GO:0070076) | 2.82331829 |
| 148 | respiratory burst (GO:0045730) | 2.80686992 |
| 149 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.80336734 |
| 150 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.79554337 |
| 151 | phototransduction (GO:0007602) | 2.78884120 |
| 152 | homocysteine metabolic process (GO:0050667) | 2.78184508 |
| 153 | detection of bacterium (GO:0016045) | 2.77461088 |
| 154 | detection of light stimulus (GO:0009583) | 2.76236724 |
| 155 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.76006091 |
| 156 | definitive hemopoiesis (GO:0060216) | 2.75895317 |
| 157 | nitrogen cycle metabolic process (GO:0071941) | 2.75839633 |
| 158 | tryptophan metabolic process (GO:0006568) | 2.73738524 |
| 159 | amino-acid betaine metabolic process (GO:0006577) | 2.73605060 |
| 160 | positive regulation of mitotic sister chromatid separation (GO:1901970) | 2.72613077 |
| 161 | positive regulation of mitotic metaphase/anaphase transition (GO:0045842) | 2.72613077 |
| 162 | positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101) | 2.72613077 |
| 163 | detection of light stimulus involved in sensory perception (GO:0050962) | 2.72392553 |
| 164 | detection of light stimulus involved in visual perception (GO:0050908) | 2.72392553 |
| 165 | proline metabolic process (GO:0006560) | 2.71906423 |
| 166 | phototransduction, visible light (GO:0007603) | 2.70508965 |
| 167 | fatty acid transmembrane transport (GO:1902001) | 2.69354072 |
| 168 | response to arsenic-containing substance (GO:0046685) | 2.69254707 |
| 169 | carnitine shuttle (GO:0006853) | 2.66881524 |
| 170 | negative regulation of cholesterol transport (GO:0032375) | 2.66577160 |
| 171 | negative regulation of sterol transport (GO:0032372) | 2.66577160 |
| 172 | platelet formation (GO:0030220) | 2.63262395 |
| 173 | high-density lipoprotein particle remodeling (GO:0034375) | 2.63244349 |
| 174 | macroautophagy (GO:0016236) | 2.62961402 |
| 175 | acylglycerol homeostasis (GO:0055090) | 2.62003982 |
| 176 | triglyceride homeostasis (GO:0070328) | 2.62003982 |
| 177 | heme transport (GO:0015886) | 2.61589851 |
| 178 | plasma lipoprotein particle organization (GO:0071827) | 2.61065338 |
| 179 | negative regulation of fibrinolysis (GO:0051918) | 2.60958697 |
| 180 | negative regulation of histone methylation (GO:0031061) | 2.59929565 |
| 181 | glutamate metabolic process (GO:0006536) | 2.58919765 |
| 182 | regulation of translational fidelity (GO:0006450) | 2.58379495 |
| 183 | cholesterol efflux (GO:0033344) | 2.58321646 |
| 184 | histone H3-K9 demethylation (GO:0033169) | 2.58228950 |
| 185 | aspartate family amino acid catabolic process (GO:0009068) | 2.56491190 |
| 186 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 cla | 2.52306696 |
| 187 | histone H3-K36 demethylation (GO:0070544) | 2.52144040 |
| 188 | complement activation, alternative pathway (GO:0006957) | 2.51041194 |
| 189 | response to dexamethasone (GO:0071548) | 2.50515718 |
| 190 | protein-lipid complex subunit organization (GO:0071825) | 2.50434820 |
| 191 | valine metabolic process (GO:0006573) | 2.50142805 |
| 192 | negative regulation of fatty acid metabolic process (GO:0045922) | 2.49199510 |
| 193 | regulation of protein activation cascade (GO:2000257) | 2.49050320 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.54431945 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.08963987 |
| 3 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 3.85476636 |
| 4 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 3.67572709 |
| 5 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.57424087 |
| 6 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 3.40261170 |
| 7 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.19784558 |
| 8 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.18079005 |
| 9 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.01638812 |
| 10 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 3.00090887 |
| 11 | * MYC_22102868_ChIP-Seq_BL_Human | 2.97532471 |
| 12 | GATA1_22025678_ChIP-Seq_K562_Human | 2.90696941 |
| 13 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.90084246 |
| 14 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.89914442 |
| 15 | MYB_26560356_Chip-Seq_TH2_Human | 2.88436324 |
| 16 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.81565569 |
| 17 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 2.81564107 |
| 18 | * GATA1_19941826_ChIP-Seq_K562_Human | 2.75577317 |
| 19 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.69464771 |
| 20 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.56763603 |
| 21 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.56069188 |
| 22 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.55893307 |
| 23 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 2.53202089 |
| 24 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.47752341 |
| 25 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.40106524 |
| 26 | SPI1_23127762_ChIP-Seq_K562_Human | 2.37367029 |
| 27 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.30063543 |
| 28 | * EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.29456084 |
| 29 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.28218391 |
| 30 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.26396706 |
| 31 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 2.23861195 |
| 32 | TCF7_22412390_ChIP-Seq_EML_Mouse | 2.20679335 |
| 33 | * KDM2B_26808549_Chip-Seq_DND41_Human | 2.14155428 |
| 34 | * SPI1_23547873_ChIP-Seq_NB4_Human | 2.13299073 |
| 35 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.09344166 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.04862824 |
| 37 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.02635254 |
| 38 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.98385475 |
| 39 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.98113619 |
| 40 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.95537914 |
| 41 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.94779011 |
| 42 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.90746145 |
| 43 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.87870115 |
| 44 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.87169543 |
| 45 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.78989020 |
| 46 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.77081409 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.76862043 |
| 48 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.75281845 |
| 49 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.72095474 |
| 50 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.71136070 |
| 51 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.70010931 |
| 52 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.69987160 |
| 53 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 1.68100176 |
| 54 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.65857229 |
| 55 | * GATA2_19941826_ChIP-Seq_K562_Human | 1.63974187 |
| 56 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.62515649 |
| 57 | KLF1_20508144_ChIP-Seq_FETAL-LIVER-ERYTHROID_Mouse | 1.62164540 |
| 58 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.60320544 |
| 59 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.59936022 |
| 60 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.59716324 |
| 61 | * KDM2B_26808549_Chip-Seq_K562_Human | 1.59106598 |
| 62 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.57663756 |
| 63 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.57635305 |
| 64 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.57627089 |
| 65 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.57201579 |
| 66 | * MAF_26560356_Chip-Seq_TH1_Human | 1.50719835 |
| 67 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.45629104 |
| 68 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43593852 |
| 69 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.39791509 |
| 70 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.39322152 |
| 71 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.37677703 |
| 72 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.35998756 |
| 73 | * CREB1_26743006_Chip-Seq_LNCaP_Human | 1.33562616 |
| 74 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.31334444 |
| 75 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.30448100 |
| 76 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.30248616 |
| 77 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.29367834 |
| 78 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.28556324 |
| 79 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.27954093 |
| 80 | GATA3_26560356_Chip-Seq_TH2_Human | 1.27916830 |
| 81 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.26266818 |
| 82 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.26151061 |
| 83 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.25583769 |
| 84 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.25232022 |
| 85 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.24136303 |
| 86 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.23826109 |
| 87 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.21278123 |
| 88 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.20590472 |
| 89 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.19242722 |
| 90 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.19094105 |
| 91 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 1.18894408 |
| 92 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.15361980 |
| 93 | * RACK7_27058665_Chip-Seq_MCF-7_Human | 1.12979455 |
| 94 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.12178009 |
| 95 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.11862882 |
| 96 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.11822439 |
| 97 | * CHD1_26751641_Chip-Seq_LNCaP_Human | 1.11818714 |
| 98 | CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.10556779 |
| 99 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.10392325 |
| 100 | P68_20966046_ChIP-Seq_HELA_Human | 1.09607676 |
| 101 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.09502475 |
| 102 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.08794430 |
| 103 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.08410348 |
| 104 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.07861813 |
| 105 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.07675956 |
| 106 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 1.06890145 |
| 107 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06542842 |
| 108 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.06534111 |
| 109 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.05485211 |
| 110 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.05415616 |
| 111 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.05258882 |
| 112 | * FOXM1_26100407_CHIP-SEQ_Hek293_flp-in_Human | 1.03885253 |
| 113 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.02905232 |
| 114 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.02854041 |
| 115 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.02684817 |
| 116 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.02087558 |
| 117 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.01920077 |
| 118 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.01723784 |
| 119 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.01135550 |
| 120 | * FOXA1_26743006_Chip-Seq_LNCaP-abl_Human | 1.01119145 |
| 121 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.01062029 |
| 122 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.99566836 |
| 123 | VDR_24763502_ChIP-Seq_THP-1_Human | 0.98673135 |
| 124 | * CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.98523550 |
| 125 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.98325475 |
| 126 | TFEB_21752829_ChIP-Seq_HELA_Human | 0.98283708 |
| 127 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.97226785 |
| 128 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 0.97167372 |
| 129 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.95807510 |
| 130 | * ATF3_27146783_Chip-Seq_COLON_Human | 0.94984143 |
| 131 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.94415103 |
| 132 | SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.94283135 |
| 133 | PKCTHETA_26484144_Chip-Seq_BREAST_Human | 0.93607791 |
| 134 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 0.91115433 |
| 135 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.90987884 |
| 136 | * MAF_26560356_Chip-Seq_TH2_Human | 0.88659502 |
| 137 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.88263630 |
| 138 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 0.87358509 |
| 139 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.87207340 |
| 140 | * MYB_26560356_Chip-Seq_TH1_Human | 0.86750684 |
| 141 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.85058258 |
| 142 | RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.83738858 |
| 143 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 0.83727086 |
| 144 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.83232662 |
| 145 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.77608172 |
| 146 | KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 0.77433259 |
| 147 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.74783490 |
| 148 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.74524460 |
| 149 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.74299416 |
| 150 | GATA3_26560356_Chip-Seq_TH1_Human | 0.73363205 |
| 151 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.70569176 |
| 152 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.70210141 |
| 153 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.68685099 |
| 154 | TP53_16413492_ChIP-PET_HCT116_Human | 0.68340621 |
| 155 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.67841522 |
| 156 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.67798897 |
| 157 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 0.66659709 |
| 158 | * SALL4_22934838_ChIP-ChIP_CD34+_Human | 0.66370089 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003656_abnormal_erythrocyte_physiolo | 5.55496950 |
| 2 | MP0008260_abnormal_autophagy | 4.53033854 |
| 3 | MP0000569_abnormal_digit_pigmentation | 4.19026105 |
| 4 | MP0002139_abnormal_hepatobiliary_system | 3.97011919 |
| 5 | MP0003011_delayed_dark_adaptation | 3.87028740 |
| 6 | MP0005360_urolithiasis | 3.80556864 |
| 7 | MP0004147_increased_porphyrin_level | 3.55562495 |
| 8 | MP0005365_abnormal_bile_salt | 3.47029886 |
| 9 | MP0005551_abnormal_eye_electrophysiolog | 3.46800680 |
| 10 | MP0003763_abnormal_thymus_physiology | 3.17227884 |
| 11 | MP0005085_abnormal_gallbladder_physiolo | 3.05172110 |
| 12 | MP0005451_abnormal_body_composition | 3.01894546 |
| 13 | MP0006072_abnormal_retinal_apoptosis | 2.95758666 |
| 14 | MP0003724_increased_susceptibility_to | 2.85564430 |
| 15 | MP0001835_abnormal_antigen_presentation | 2.84508866 |
| 16 | MP0005083_abnormal_biliary_tract | 2.78999934 |
| 17 | MP0003303_peritoneal_inflammation | 2.75333211 |
| 18 | MP0003252_abnormal_bile_duct | 2.56375577 |
| 19 | MP0005253_abnormal_eye_physiology | 2.56340172 |
| 20 | MP0003787_abnormal_imprinting | 2.55448342 |
| 21 | MP0004381_abnormal_hair_follicle | 2.43936736 |
| 22 | MP0003705_abnormal_hypodermis_morpholog | 2.37935209 |
| 23 | MP0001800_abnormal_humoral_immune | 2.37915781 |
| 24 | MP0003172_abnormal_lysosome_physiology | 2.24589637 |
| 25 | MP0002396_abnormal_hematopoietic_system | 2.19887925 |
| 26 | MP0002398_abnormal_bone_marrow | 2.18818795 |
| 27 | MP0000685_abnormal_immune_system | 2.13781511 |
| 28 | MP0003436_decreased_susceptibility_to | 2.13480184 |
| 29 | MP0003221_abnormal_cardiomyocyte_apopto | 2.00561732 |
| 30 | MP0002420_abnormal_adaptive_immunity | 1.93880045 |
| 31 | MP0008875_abnormal_xenobiotic_pharmacok | 1.90869585 |
| 32 | MP0001819_abnormal_immune_cell | 1.90826166 |
| 33 | MP0002722_abnormal_immune_system | 1.88313255 |
| 34 | MP0005076_abnormal_cell_differentiation | 1.88108661 |
| 35 | MP0005671_abnormal_response_to | 1.85752342 |
| 36 | MP0000689_abnormal_spleen_morphology | 1.85193692 |
| 37 | MP0002723_abnormal_immune_serum | 1.84721869 |
| 38 | MP0002419_abnormal_innate_immunity | 1.84299315 |
| 39 | MP0005025_abnormal_response_to | 1.82801624 |
| 40 | MP0000015_abnormal_ear_pigmentation | 1.82387005 |
| 41 | MP0001324_abnormal_eye_pigmentation | 1.79003084 |
| 42 | MP0002452_abnormal_antigen_presenting | 1.77257103 |
| 43 | MP0005000_abnormal_immune_tolerance | 1.76999105 |
| 44 | MP0002653_abnormal_ependyma_morphology | 1.76444384 |
| 45 | MP0005075_abnormal_melanosome_morpholog | 1.75355135 |
| 46 | MP0000716_abnormal_immune_system | 1.72741365 |
| 47 | MP0002405_respiratory_system_inflammati | 1.71931298 |
| 48 | MP0010329_abnormal_lipoprotein_level | 1.71046820 |
| 49 | MP0004883_abnormal_blood_vessel | 1.69034140 |
| 50 | MP0009278_abnormal_bone_marrow | 1.65799733 |
| 51 | MP0003300_gastrointestinal_ulcer | 1.65192552 |
| 52 | MP0005195_abnormal_posterior_eye | 1.63115671 |
| 53 | MP0005391_vision/eye_phenotype | 1.57928188 |
| 54 | MP0004233_abnormal_muscle_weight | 1.55898365 |
| 55 | MP0000609_abnormal_liver_physiology | 1.53167380 |
| 56 | MP0002429_abnormal_blood_cell | 1.53059568 |
| 57 | MP0001790_abnormal_immune_system | 1.52165982 |
| 58 | MP0005387_immune_system_phenotype | 1.52165982 |
| 59 | MP0005310_abnormal_salivary_gland | 1.51963820 |
| 60 | MP0002009_preneoplasia | 1.47111355 |
| 61 | MP0005174_abnormal_tail_pigmentation | 1.46231728 |
| 62 | MP0003866_abnormal_defecation | 1.44203475 |
| 63 | MP0009785_altered_susceptibility_to | 1.43989768 |
| 64 | MP0003828_pulmonary_edema | 1.40923609 |
| 65 | MP0003111_abnormal_nucleus_morphology | 1.39854596 |
| 66 | MP0005187_abnormal_penis_morphology | 1.39794060 |
| 67 | MP0008877_abnormal_DNA_methylation | 1.38673211 |
| 68 | MP0004947_skin_inflammation | 1.38328549 |
| 69 | MP0004264_abnormal_extraembryonic_tissu | 1.36887487 |
| 70 | MP0001666_abnormal_nutrient_absorption | 1.35398822 |
| 71 | MP0009053_abnormal_anal_canal | 1.34604678 |
| 72 | MP0010030_abnormal_orbit_morphology | 1.30278499 |
| 73 | MP0005397_hematopoietic_system_phenotyp | 1.30015494 |
| 74 | MP0001545_abnormal_hematopoietic_system | 1.30015494 |
| 75 | MP0002006_tumorigenesis | 1.29109242 |
| 76 | MP0003890_abnormal_embryonic-extraembry | 1.27989350 |
| 77 | MP0009333_abnormal_splenocyte_physiolog | 1.27241040 |
| 78 | MP0004019_abnormal_vitamin_homeostasis | 1.26976573 |
| 79 | MP0002138_abnormal_hepatobiliary_system | 1.22772207 |
| 80 | MP0010307_abnormal_tumor_latency | 1.22094790 |
| 81 | MP0010352_gastrointestinal_tract_polyps | 1.20084749 |
| 82 | MP0009840_abnormal_foam_cell | 1.18566826 |
| 83 | MP0002166_altered_tumor_susceptibility | 1.15954755 |
| 84 | MP0000858_altered_metastatic_potential | 1.14547476 |
| 85 | MP0003690_abnormal_glial_cell | 1.13038488 |
| 86 | MP0008057_abnormal_DNA_replication | 1.10768503 |
| 87 | MP0002086_abnormal_extraembryonic_tissu | 1.09956877 |
| 88 | MP0002332_abnormal_exercise_endurance | 1.09890796 |
| 89 | MP0001851_eye_inflammation | 1.09072859 |
| 90 | MP0008961_abnormal_basal_metabolism | 1.09025402 |
| 91 | MP0001764_abnormal_homeostasis | 1.08760983 |
| 92 | MP0004130_abnormal_muscle_cell | 1.08099313 |
| 93 | MP0001845_abnormal_inflammatory_respons | 1.05708845 |
| 94 | MP0004197_abnormal_fetal_growth/weight/ | 1.04207653 |
| 95 | MP0005319_abnormal_enzyme/_coenzyme | 1.03992514 |
| 96 | MP0002132_abnormal_respiratory_system | 1.03063043 |
| 97 | MP0010630_abnormal_cardiac_muscle | 0.99261117 |
| 98 | MP0000598_abnormal_liver_morphology | 0.98919776 |
| 99 | MP0002088_abnormal_embryonic_growth/wei | 0.96542468 |
| 100 | MP0003984_embryonic_growth_retardation | 0.95892710 |
| 101 | MP0010155_abnormal_intestine_physiology | 0.95211908 |
| 102 | MP0008775_abnormal_heart_ventricle | 0.94858218 |
| 103 | MP0003191_abnormal_cellular_cholesterol | 0.94629584 |
| 104 | MP0002697_abnormal_eye_size | 0.94018805 |
| 105 | MP0004484_altered_response_of | 0.93472538 |
| 106 | MP0005220_abnormal_exocrine_pancreas | 0.92849485 |
| 107 | MP0005332_abnormal_amino_acid | 0.91765041 |
| 108 | MP0003121_genomic_imprinting | 0.91612044 |
| 109 | MP0001697_abnormal_embryo_size | 0.91186985 |
| 110 | MP0005248_abnormal_Harderian_gland | 0.91084776 |
| 111 | MP0005380_embryogenesis_phenotype | 0.90928389 |
| 112 | MP0001672_abnormal_embryogenesis/_devel | 0.90928389 |
| 113 | MP0010094_abnormal_chromosome_stability | 0.89986205 |
| 114 | MP0008789_abnormal_olfactory_epithelium | 0.89398027 |
| 115 | MP0005621_abnormal_cell_physiology | 0.89216796 |
| 116 | MP0003567_abnormal_fetal_cardiomyocyte | 0.87879010 |
| 117 | MP0000350_abnormal_cell_proliferation | 0.87020257 |
| 118 | MP0005164_abnormal_response_to | 0.86605466 |
| 119 | MP0009672_abnormal_birth_weight | 0.86334128 |
| 120 | MP0006082_CNS_inflammation | 0.86301007 |
| 121 | MP0004185_abnormal_adipocyte_glucose | 0.85080376 |
| 122 | MP0002118_abnormal_lipid_homeostasis | 0.84883413 |
| 123 | MP0003868_abnormal_feces_composition | 0.83897449 |
| 124 | MP0003091_abnormal_cell_migration | 0.82018958 |
| 125 | MP0005666_abnormal_adipose_tissue | 0.81923467 |
| 126 | MP0005636_abnormal_mineral_homeostasis | 0.81310613 |
| 127 | MP0001293_anophthalmia | 0.80832704 |
| 128 | MP0000465_gastrointestinal_hemorrhage | 0.80522182 |
| 129 | MP0000371_diluted_coat_color | 0.79073732 |
| 130 | MP0002092_abnormal_eye_morphology | 0.78697935 |
| 131 | MP0002148_abnormal_hypersensitivity_rea | 0.78449821 |
| 132 | MP0001730_embryonic_growth_arrest | 0.77866922 |
| 133 | MP0002084_abnormal_developmental_patter | 0.77762720 |
| 134 | MP0003077_abnormal_cell_cycle | 0.77084437 |
| 135 | MP0009703_decreased_birth_body | 0.75433859 |
| 136 | MP0005501_abnormal_skin_physiology | 0.75091515 |
| 137 | MP0009643_abnormal_urine_homeostasis | 0.74755078 |
| 138 | MP0005394_taste/olfaction_phenotype | 0.74127657 |
| 139 | MP0005499_abnormal_olfactory_system | 0.74127657 |
| 140 | MP0002928_abnormal_bile_duct | 0.73353385 |
| 141 | MP0001915_intracranial_hemorrhage | 0.73045235 |
| 142 | MP0002090_abnormal_vision | 0.71707749 |
| 143 | MP0000266_abnormal_heart_morphology | 0.70782762 |
| 144 | MP0009763_increased_sensitivity_to | 0.70381480 |
| 145 | MP0009765_abnormal_xenobiotic_induced | 0.69918501 |
| 146 | MP0002080_prenatal_lethality | 0.69726747 |
| 147 | MP0001849_ear_inflammation | 0.69656208 |
| 148 | MP0003806_abnormal_nucleotide_metabolis | 0.68771827 |
| 149 | MP0002085_abnormal_embryonic_tissue | 0.68108289 |
| 150 | MP0002269_muscular_atrophy | 0.67960064 |
| 151 | MP0000604_amyloidosis | 0.67777933 |
| 152 | MP0004808_abnormal_hematopoietic_stem | 0.67620131 |
| 153 | MP0005384_cellular_phenotype | 0.67425357 |
| 154 | MP0002229_neurodegeneration | 0.67400926 |
| 155 | MP0003329_amyloid_beta_deposits | 0.67250689 |
| 156 | MP0001533_abnormal_skeleton_physiology | 0.66836515 |
| 157 | MP0003632_abnormal_nervous_system | 0.66805777 |
| 158 | MP0004087_abnormal_muscle_fiber | 0.65979097 |
| 159 | MP0008995_early_reproductive_senescence | 0.65447980 |
| 160 | MP0002971_abnormal_brown_adipose | 0.65083927 |
| 161 | MP0005464_abnormal_platelet_physiology | 0.65027404 |
| 162 | MP0009764_decreased_sensitivity_to | 0.64040000 |
| 163 | MP0001663_abnormal_digestive_system | 0.63824247 |
| 164 | MP0009115_abnormal_fat_cell | 0.62963065 |
| 165 | MP0008469_abnormal_protein_level | 0.62891988 |
| 166 | MP0005409_darkened_coat_color | 0.62580090 |
| 167 | MP0005376_homeostasis/metabolism_phenot | 0.62519510 |
| 168 | MP0002970_abnormal_white_adipose | 0.62418830 |
| 169 | MP0005408_hypopigmentation | 0.62401291 |
| 170 | MP0005266_abnormal_metabolism | 0.62268325 |
| 171 | MP0008770_decreased_survivor_rate | 0.61809381 |
| 172 | MP0008874_decreased_physiological_sensi | 0.61651024 |
| 173 | MP0003183_abnormal_peptide_metabolism | 0.61531566 |
| 174 | MP0000703_abnormal_thymus_morphology | 0.60990877 |
| 175 | MP0002019_abnormal_tumor_incidence | 0.60545892 |
| 176 | MP0001853_heart_inflammation | 0.55806325 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Hypochromic microcytic anemia (HP:0004840) | 7.38352624 |
| 2 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 6.95590903 |
| 3 | * Poikilocytosis (HP:0004447) | 6.36484996 |
| 4 | Congenital stationary night blindness (HP:0007642) | 6.33279986 |
| 5 | Chorioretinal atrophy (HP:0000533) | 5.55291122 |
| 6 | T lymphocytopenia (HP:0005403) | 5.38564581 |
| 7 | Pendular nystagmus (HP:0012043) | 5.32900638 |
| 8 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 5.24143267 |
| 9 | Pigmentary retinal degeneration (HP:0001146) | 5.22127979 |
| 10 | Recurrent bacterial skin infections (HP:0005406) | 5.18639413 |
| 11 | Bony spicule pigmentary retinopathy (HP:0007737) | 5.14641895 |
| 12 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 4.96075597 |
| 13 | Abnormality of T cell number (HP:0011839) | 4.93716360 |
| 14 | Central scotoma (HP:0000603) | 4.93263237 |
| 15 | Acanthocytosis (HP:0001927) | 4.85992598 |
| 16 | Abnormal rod and cone electroretinograms (HP:0008323) | 4.81397324 |
| 17 | Eczematoid dermatitis (HP:0000976) | 4.59852836 |
| 18 | Recurrent abscess formation (HP:0002722) | 4.52748139 |
| 19 | Reticulocytosis (HP:0001923) | 4.38019238 |
| 20 | Posterior subcapsular cataract (HP:0007787) | 4.30404744 |
| 21 | Gastrointestinal infarctions (HP:0005244) | 4.15111342 |
| 22 | Cholelithiasis (HP:0001081) | 4.01224209 |
| 23 | Abolished electroretinogram (ERG) (HP:0000550) | 3.90344426 |
| 24 | Abnormality of macular pigmentation (HP:0008002) | 3.90036450 |
| 25 | Scotoma (HP:0000575) | 3.89193866 |
| 26 | Recurrent fungal infections (HP:0002841) | 3.74568587 |
| 27 | Slow saccadic eye movements (HP:0000514) | 3.59215365 |
| 28 | Abnormal gallbladder morphology (HP:0012437) | 3.55087241 |
| 29 | Hypochromic anemia (HP:0001931) | 3.54257591 |
| 30 | Optic neuritis (HP:0100653) | 3.50365272 |
| 31 | Retrobulbar optic neuritis (HP:0100654) | 3.50365272 |
| 32 | Spontaneous hematomas (HP:0007420) | 3.44471701 |
| 33 | Gingival bleeding (HP:0000225) | 3.41174959 |
| 34 | Abnormality of the fingertips (HP:0001211) | 3.38579520 |
| 35 | Myositis (HP:0100614) | 3.37963696 |
| 36 | Recurrent viral infections (HP:0004429) | 3.30827396 |
| 37 | Abnormality of T cells (HP:0002843) | 3.29156068 |
| 38 | Orchitis (HP:0100796) | 3.28168720 |
| 39 | Hyperbilirubinemia (HP:0002904) | 3.26559091 |
| 40 | Gingivitis (HP:0000230) | 3.25461608 |
| 41 | Recurrent skin infections (HP:0001581) | 3.24760941 |
| 42 | Type II diabetes mellitus (HP:0005978) | 3.24140475 |
| 43 | Cone-rod dystrophy (HP:0000548) | 3.21882106 |
| 44 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.13903799 |
| 45 | Deep venous thrombosis (HP:0002625) | 3.11881309 |
| 46 | Postural instability (HP:0002172) | 3.10856168 |
| 47 | Dyschromatopsia (HP:0007641) | 3.09221236 |
| 48 | Insomnia (HP:0100785) | 3.08374819 |
| 49 | Macular degeneration (HP:0000608) | 3.08169654 |
| 50 | Prolonged bleeding time (HP:0003010) | 3.00707471 |
| 51 | Decreased central vision (HP:0007663) | 2.99378016 |
| 52 | Subcapsular cataract (HP:0000523) | 2.96174607 |
| 53 | Subacute progressive viral hepatitis (HP:0006572) | 2.96004413 |
| 54 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.94590567 |
| 55 | Leukocytosis (HP:0001974) | 2.92536846 |
| 56 | Recurrent cutaneous fungal infections (HP:0011370) | 2.92449645 |
| 57 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.92449645 |
| 58 | Keratoconjunctivitis sicca (HP:0001097) | 2.89456457 |
| 59 | Arterial thrombosis (HP:0004420) | 2.86273075 |
| 60 | Orthostatic hypotension (HP:0001278) | 2.86153785 |
| 61 | Visual hallucinations (HP:0002367) | 2.83517119 |
| 62 | Vitreoretinal degeneration (HP:0000655) | 2.79503897 |
| 63 | Polycythemia (HP:0001901) | 2.78876017 |
| 64 | Epistaxis (HP:0000421) | 2.74068460 |
| 65 | Severe visual impairment (HP:0001141) | 2.73866530 |
| 66 | Encephalitis (HP:0002383) | 2.71130444 |
| 67 | Meningitis (HP:0001287) | 2.70995294 |
| 68 | Diaphragmatic weakness (HP:0009113) | 2.66915767 |
| 69 | Papillary thyroid carcinoma (HP:0002895) | 2.66819431 |
| 70 | Viral hepatitis (HP:0006562) | 2.65688248 |
| 71 | Hepatocellular carcinoma (HP:0001402) | 2.62566945 |
| 72 | Keratoconjunctivitis (HP:0001096) | 2.62090510 |
| 73 | Microcytic anemia (HP:0001935) | 2.61569790 |
| 74 | Chronic obstructive pulmonary disease (HP:0006510) | 2.60658701 |
| 75 | Obstructive lung disease (HP:0006536) | 2.60658701 |
| 76 | Attenuation of retinal blood vessels (HP:0007843) | 2.60012608 |
| 77 | Chest pain (HP:0100749) | 2.59217428 |
| 78 | Colitis (HP:0002583) | 2.59198936 |
| 79 | Cellulitis (HP:0100658) | 2.58291380 |
| 80 | Autoimmune hemolytic anemia (HP:0001890) | 2.58044255 |
| 81 | Abnormality of the gallbladder (HP:0005264) | 2.57862503 |
| 82 | Stomatitis (HP:0010280) | 2.55927991 |
| 83 | Intrahepatic cholestasis (HP:0001406) | 2.55139515 |
| 84 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.53600917 |
| 85 | Abnormality of macrophages (HP:0004311) | 2.52560019 |
| 86 | Inflammation of the large intestine (HP:0002037) | 2.50071232 |
| 87 | Vasculitis (HP:0002633) | 2.49281391 |
| 88 | Granulocytopenia (HP:0001913) | 2.48646320 |
| 89 | Peritonitis (HP:0002586) | 2.48473393 |
| 90 | Heterotopia (HP:0002282) | 2.43684914 |
| 91 | Urticaria (HP:0001025) | 2.42601534 |
| 92 | Mediastinal lymphadenopathy (HP:0100721) | 2.41171977 |
| 93 | Gastrointestinal inflammation (HP:0004386) | 2.40530656 |
| 94 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.40133803 |
| 95 | Photophobia (HP:0000613) | 2.37880697 |
| 96 | Eosinophilia (HP:0001880) | 2.37226002 |
| 97 | Abnormality of reticulocytes (HP:0004312) | 2.33445825 |
| 98 | Cholecystitis (HP:0001082) | 2.31585168 |
| 99 | Abnormal gallbladder physiology (HP:0012438) | 2.31585168 |
| 100 | Acute myeloid leukemia (HP:0004808) | 2.30951499 |
| 101 | Resting tremor (HP:0002322) | 2.30853871 |
| 102 | Conjunctival telangiectasia (HP:0000524) | 2.27918582 |
| 103 | Volvulus (HP:0002580) | 2.25105456 |
| 104 | Hypoplasia of the thymus (HP:0000778) | 2.24143736 |
| 105 | Osteomyelitis (HP:0002754) | 2.23841341 |
| 106 | Recurrent bronchitis (HP:0002837) | 2.22375484 |
| 107 | Panhypogammaglobulinemia (HP:0003139) | 2.20170929 |
| 108 | Abnormality of eosinophils (HP:0001879) | 2.20145125 |
| 109 | Constricted visual fields (HP:0001133) | 2.20094173 |
| 110 | IgM deficiency (HP:0002850) | 2.19926317 |
| 111 | Xanthomatosis (HP:0000991) | 2.19126950 |
| 112 | Periodontitis (HP:0000704) | 2.17587144 |
| 113 | Hypobetalipoproteinemia (HP:0003563) | 2.16986545 |
| 114 | Macroorchidism (HP:0000053) | 2.15180102 |
| 115 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.14081437 |
| 116 | Fatigue (HP:0012378) | 2.11695265 |
| 117 | Acute hepatic failure (HP:0006554) | 2.11508414 |
| 118 | Ketosis (HP:0001946) | 2.10444627 |
| 119 | Anorexia (HP:0002039) | 2.09414507 |
| 120 | Pustule (HP:0200039) | 2.05042514 |
| 121 | Keratoconus (HP:0000563) | 2.04891101 |
| 122 | Increased corneal curvature (HP:0100692) | 2.04891101 |
| 123 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.03911177 |
| 124 | Papilloma (HP:0012740) | 2.03770567 |
| 125 | Verrucae (HP:0200043) | 2.03770567 |
| 126 | IgA deficiency (HP:0002720) | 2.02233842 |
| 127 | Abnormal platelet volume (HP:0011876) | 2.01819312 |
| 128 | Lymphopenia (HP:0001888) | 2.01790009 |
| 129 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.98108361 |
| 130 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.97835021 |
| 131 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 1.97824129 |
| 132 | Osteomalacia (HP:0002749) | 1.94270608 |
| 133 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.94118911 |
| 134 | Abnormality of the peritoneum (HP:0002585) | 1.93876390 |
| 135 | Hyperammonemia (HP:0001987) | 1.93822727 |
| 136 | Hemoptysis (HP:0002105) | 1.93593407 |
| 137 | Paralysis (HP:0003470) | 1.92910633 |
| 138 | Abnormality of T cell physiology (HP:0011840) | 1.92358562 |
| 139 | Neonatal hypoglycemia (HP:0001998) | 1.92340211 |
| 140 | Abnormality of the common coagulation pathway (HP:0010990) | 1.88894327 |
| 141 | Pulmonary embolism (HP:0002204) | 1.88480020 |
| 142 | Hyperacusis (HP:0010780) | 1.87220028 |
| 143 | Cortical dysplasia (HP:0002539) | 1.86925321 |
| 144 | Amaurosis fugax (HP:0100576) | 1.86494063 |
| 145 | Severe combined immunodeficiency (HP:0004430) | 1.85676997 |
| 146 | Hypolipoproteinemia (HP:0010981) | 1.85430466 |
| 147 | Hypoalphalipoproteinemia (HP:0003233) | 1.85298167 |
| 148 | Cerebral inclusion bodies (HP:0100314) | 1.85162137 |
| 149 | Back pain (HP:0003418) | 1.84527557 |
| 150 | Autoimmune thrombocytopenia (HP:0001973) | 1.83370563 |
| 151 | Dysautonomia (HP:0002459) | 1.83083990 |
| 152 | Dysmetric saccades (HP:0000641) | 1.81599004 |
| 153 | Pulmonary infiltrates (HP:0002113) | 1.81233016 |
| 154 | Ketoacidosis (HP:0001993) | 1.80799834 |
| 155 | Pseudobulbar signs (HP:0002200) | 1.79806580 |
| 156 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.79432309 |
| 157 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.79432309 |
| 158 | Elfin facies (HP:0004428) | 1.78635493 |
| 159 | Complement deficiency (HP:0004431) | 1.77447446 |
| 160 | Aplasia/Hypoplasia of the 4th metacarpal (HP:0010042) | 1.75231599 |
| 161 | Short 4th metacarpal (HP:0010044) | 1.75231599 |
| 162 | Hypoglycemic coma (HP:0001325) | 1.73099819 |
| 163 | Progressive visual loss (HP:0000529) | 1.71862124 |
| 164 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 1.71771350 |
| 165 | Abnormality of the 4th metacarpal (HP:0010012) | 1.70733366 |
| 166 | Hyperlipoproteinemia (HP:0010980) | 1.69409700 |
| 167 | Generalized hyperpigmentation (HP:0007440) | 1.65267946 |
| 168 | Renovascular hypertension (HP:0100817) | 1.62995112 |
| 169 | Prominent nose (HP:0000448) | 1.62189900 |
| 170 | Esophageal varix (HP:0002040) | 1.61841852 |
| 171 | Hyperglycinuria (HP:0003108) | 1.60855064 |
| 172 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 1.58078474 |
| 173 | Myoglobinuria (HP:0002913) | 1.52577278 |
| 174 | Hypercholesterolemia (HP:0003124) | 1.51069020 |
| 175 | Epidermoid cyst (HP:0200040) | 1.50769469 |
| 176 | Abnormality of the lower motor neuron (HP:0002366) | 1.49977164 |
| 177 | Spastic diplegia (HP:0001264) | 1.49611654 |
| 178 | Lymphangioma (HP:0100764) | 1.49394766 |
| 179 | Obsessive-compulsive behavior (HP:0000722) | 1.49028882 |
| 180 | Increased nuchal translucency (HP:0010880) | 1.45374384 |
| 181 | Myocardial infarction (HP:0001658) | 1.45230956 |
| 182 | Short 5th finger (HP:0009237) | 1.45033655 |
| 183 | Gout (HP:0001997) | 1.42422629 |
| 184 | Truncal obesity (HP:0001956) | 1.42179628 |
| 185 | Childhood onset (HP:0011463) | 1.42118755 |
| 186 | Abnormality of glycine metabolism (HP:0010895) | 1.41629534 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.12576599 |
| 2 | MAP3K10 | 3.95678327 |
| 3 | TRIB3 | 3.44796191 |
| 4 | CDK12 | 3.30532629 |
| 5 | EEF2K | 2.91985072 |
| 6 | PKN2 | 2.88521772 |
| 7 | ICK | 2.82843174 |
| 8 | FGR | 2.46112332 |
| 9 | BLK | 2.41350134 |
| 10 | IKBKE | 2.15974581 |
| 11 | PRPF4B | 2.12920924 |
| 12 | DYRK1B | 2.00617867 |
| 13 | SIK1 | 1.98872536 |
| 14 | CDK6 | 1.98594373 |
| 15 | WNK1 | 1.97710672 |
| 16 | CAMK1D | 1.96842639 |
| 17 | TAOK3 | 1.95112767 |
| 18 | LATS1 | 1.92265969 |
| 19 | STK4 | 1.89734777 |
| 20 | JAK3 | 1.88297586 |
| 21 | RIPK1 | 1.87618105 |
| 22 | SYK | 1.82594034 |
| 23 | TXK | 1.79164922 |
| 24 | FES | 1.79069299 |
| 25 | BTK | 1.76986593 |
| 26 | IRAK4 | 1.72716877 |
| 27 | CAMK1G | 1.68551056 |
| 28 | MAP3K2 | 1.63433716 |
| 29 | CDC7 | 1.61966377 |
| 30 | NEK2 | 1.55195618 |
| 31 | PTK6 | 1.49161702 |
| 32 | PTK2B | 1.48016053 |
| 33 | KSR2 | 1.46983795 |
| 34 | BMPR2 | 1.44746313 |
| 35 | MAPK11 | 1.42668913 |
| 36 | BRD4 | 1.40926471 |
| 37 | PRKAA1 | 1.40142518 |
| 38 | MAP3K6 | 1.39721351 |
| 39 | MAP3K14 | 1.38836820 |
| 40 | GRK5 | 1.38383623 |
| 41 | PDGFRA | 1.36819736 |
| 42 | ZAP70 | 1.32241163 |
| 43 | ERN1 | 1.29233270 |
| 44 | MARK2 | 1.27989609 |
| 45 | HCK | 1.27767274 |
| 46 | STK10 | 1.26924995 |
| 47 | JAK1 | 1.26904613 |
| 48 | MTOR | 1.26623575 |
| 49 | FGFR4 | 1.26387485 |
| 50 | TEC | 1.26044150 |
| 51 | MAP3K1 | 1.25517998 |
| 52 | MARK3 | 1.24448902 |
| 53 | ITK | 1.24372049 |
| 54 | KSR1 | 1.24294039 |
| 55 | PIK3CG | 1.22735794 |
| 56 | YES1 | 1.19686298 |
| 57 | EIF2AK1 | 1.17632076 |
| 58 | NLK | 1.16169909 |
| 59 | CDK4 | 1.15574534 |
| 60 | NEK1 | 1.15337612 |
| 61 | PIM1 | 1.15306781 |
| 62 | DYRK3 | 1.14774426 |
| 63 | SGK3 | 1.13577386 |
| 64 | GRK1 | 1.12123308 |
| 65 | BCKDK | 1.09721131 |
| 66 | PINK1 | 1.09214626 |
| 67 | MAP3K13 | 1.08776611 |
| 68 | CDK9 | 1.08005655 |
| 69 | MAP3K7 | 1.06822189 |
| 70 | LYN | 1.06771810 |
| 71 | PLK2 | 1.04843866 |
| 72 | TAOK1 | 1.04135375 |
| 73 | BMX | 1.03910597 |
| 74 | TTN | 1.03182648 |
| 75 | CLK1 | 1.02558572 |
| 76 | HIPK2 | 1.02032949 |
| 77 | IRAK1 | 0.99566976 |
| 78 | RAF1 | 0.98503981 |
| 79 | STK3 | 0.98102351 |
| 80 | MAP4K1 | 0.97539575 |
| 81 | DDR2 | 0.96124519 |
| 82 | MAP3K3 | 0.95683579 |
| 83 | PRKAA2 | 0.94992333 |
| 84 | RPS6KB2 | 0.93598436 |
| 85 | LCK | 0.93514990 |
| 86 | JAK2 | 0.90003180 |
| 87 | CAMKK2 | 0.89386579 |
| 88 | DYRK1A | 0.87936434 |
| 89 | CDC42BPA | 0.86977150 |
| 90 | SIK2 | 0.83759558 |
| 91 | IRAK2 | 0.82723973 |
| 92 | GRK6 | 0.79524868 |
| 93 | DMPK | 0.77821750 |
| 94 | TRPM7 | 0.77088063 |
| 95 | MAP3K11 | 0.77072494 |
| 96 | MAP2K3 | 0.76722447 |
| 97 | CHUK | 0.75866102 |
| 98 | FGFR3 | 0.74996416 |
| 99 | INSRR | 0.74465866 |
| 100 | TGFBR2 | 0.74014115 |
| 101 | TAOK2 | 0.73776105 |
| 102 | PRKD2 | 0.73741804 |
| 103 | TYRO3 | 0.71518367 |
| 104 | STK11 | 0.70132410 |
| 105 | MATK | 0.67643244 |
| 106 | CSK | 0.66910249 |
| 107 | MAP3K8 | 0.65589413 |
| 108 | SGK2 | 0.65354588 |
| 109 | SCYL2 | 0.65189908 |
| 110 | PDGFRB | 0.62819722 |
| 111 | STK38 | 0.62337391 |
| 112 | MAPKAPK3 | 0.61785431 |
| 113 | EPHB1 | 0.61555935 |
| 114 | FLT3 | 0.61477535 |
| 115 | CHEK2 | 0.60762286 |
| 116 | CHEK1 | 0.59550380 |
| 117 | MAP3K5 | 0.59052748 |
| 118 | TLK1 | 0.58426286 |
| 119 | RPS6KA1 | 0.56875397 |
| 120 | TYK2 | 0.55765133 |
| 121 | LRRK2 | 0.55499075 |
| 122 | PDK1 | 0.55249082 |
| 123 | ATR | 0.54825279 |
| 124 | RPS6KL1 | 0.54221848 |
| 125 | RPS6KC1 | 0.54221848 |
| 126 | ATM | 0.54054719 |
| 127 | IKBKB | 0.53686863 |
| 128 | CAMKK1 | 0.53681484 |
| 129 | CDK2 | 0.53203933 |
| 130 | RET | 0.50070310 |
| 131 | AURKB | 0.50025868 |
| 132 | FRK | 0.48971552 |
| 133 | GSK3A | 0.48102884 |
| 134 | MELK | 0.47852256 |
| 135 | TNK2 | 0.47765395 |
| 136 | RPS6KA6 | 0.47331046 |
| 137 | MAPK14 | 0.46878116 |
| 138 | AKT2 | 0.44042519 |
| 139 | SGK1 | 0.43862454 |
| 140 | CSNK1D | 0.43705255 |
| 141 | ALK | 0.43545733 |
| 142 | PHKG1 | 0.43428108 |
| 143 | PHKG2 | 0.43428108 |
| 144 | FGFR1 | 0.43283931 |
| 145 | ERBB3 | 0.42128625 |
| 146 | NEK6 | 0.41883469 |
| 147 | CDK7 | 0.40699799 |
| 148 | PRKCH | 0.40557046 |
| 149 | CAMK4 | 0.40500877 |
| 150 | * CDK1 | 0.39150012 |
| 151 | SGK223 | 0.39017155 |
| 152 | SGK494 | 0.39017155 |
| 153 | FYN | 0.38540019 |
| 154 | PRKCQ | 0.35078170 |
| 155 | MAP2K4 | 0.34480928 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 4.66042226 |
| 2 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.18071281 |
| 3 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.99475018 |
| 4 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 2.78657137 |
| 5 | Lysine degradation_Homo sapiens_hsa00310 | 2.65162921 |
| 6 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 2.56903322 |
| 7 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.40550753 |
| 8 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 2.39163167 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.31475081 |
| 10 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 2.27525274 |
| 11 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 2.18303539 |
| 12 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 2.17626827 |
| 13 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.16931145 |
| 14 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 2.06543842 |
| 15 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 2.00204141 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.00061785 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.91750852 |
| 18 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.91362515 |
| 19 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.87376908 |
| 20 | Measles_Homo sapiens_hsa05162 | 1.87311395 |
| 21 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.85363304 |
| 22 | ABC transporters_Homo sapiens_hsa02010 | 1.83410025 |
| 23 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.75362187 |
| 24 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.74801252 |
| 25 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.74238296 |
| 26 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.71815048 |
| 27 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.66992400 |
| 28 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.55459522 |
| 29 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.52422827 |
| 30 | Malaria_Homo sapiens_hsa05144 | 1.50535949 |
| 31 | Tuberculosis_Homo sapiens_hsa05152 | 1.50477784 |
| 32 | Renal cell carcinoma_Homo sapiens_hsa05211 | 1.49828110 |
| 33 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.47624129 |
| 34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.47067485 |
| 35 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 1.43943761 |
| 36 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.43656270 |
| 37 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.42780148 |
| 38 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.40376833 |
| 39 | Bile secretion_Homo sapiens_hsa04976 | 1.39193985 |
| 40 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.38767520 |
| 41 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.38164095 |
| 42 | Influenza A_Homo sapiens_hsa05164 | 1.36974581 |
| 43 | mTOR signaling pathway_Homo sapiens_hsa04150 | 1.35408799 |
| 44 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.35183245 |
| 45 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.34653744 |
| 46 | Platelet activation_Homo sapiens_hsa04611 | 1.34215180 |
| 47 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 1.32819160 |
| 48 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 1.32798136 |
| 49 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.27564433 |
| 50 | Apoptosis_Homo sapiens_hsa04210 | 1.25975586 |
| 51 | Thyroid cancer_Homo sapiens_hsa05216 | 1.23918729 |
| 52 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.23231777 |
| 53 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.23051718 |
| 54 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.22820844 |
| 55 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.21280099 |
| 56 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.20668552 |
| 57 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 1.17806321 |
| 58 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 1.16981379 |
| 59 | Insulin resistance_Homo sapiens_hsa04931 | 1.16933173 |
| 60 | Hepatitis C_Homo sapiens_hsa05160 | 1.16580434 |
| 61 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 1.12496440 |
| 62 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.11135809 |
| 63 | ErbB signaling pathway_Homo sapiens_hsa04012 | 1.09884889 |
| 64 | Notch signaling pathway_Homo sapiens_hsa04330 | 1.08697954 |
| 65 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.07078003 |
| 66 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.06944931 |
| 67 | Legionellosis_Homo sapiens_hsa05134 | 1.05555152 |
| 68 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.05258592 |
| 69 | Circadian rhythm_Homo sapiens_hsa04710 | 1.02973991 |
| 70 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.02833255 |
| 71 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.02437006 |
| 72 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 1.01925449 |
| 73 | Carbon metabolism_Homo sapiens_hsa01200 | 1.01383986 |
| 74 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.00232760 |
| 75 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.99269875 |
| 76 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.99183974 |
| 77 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.98770693 |
| 78 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.97608416 |
| 79 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.97455534 |
| 80 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.95421220 |
| 81 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.93077080 |
| 82 | Long-term potentiation_Homo sapiens_hsa04720 | 0.92530898 |
| 83 | Endometrial cancer_Homo sapiens_hsa05213 | 0.89789094 |
| 84 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.88835292 |
| 85 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.87020900 |
| 86 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.86502063 |
| 87 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.85345302 |
| 88 | Allograft rejection_Homo sapiens_hsa05330 | 0.85332848 |
| 89 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.84893176 |
| 90 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.84003188 |
| 91 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.79399712 |
| 92 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.79156574 |
| 93 | Alcoholism_Homo sapiens_hsa05034 | 0.78140120 |
| 94 | Sulfur relay system_Homo sapiens_hsa04122 | 0.78002180 |
| 95 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.77315771 |
| 96 | Retinol metabolism_Homo sapiens_hsa00830 | 0.75735536 |
| 97 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.75004583 |
| 98 | Peroxisome_Homo sapiens_hsa04146 | 0.74575642 |
| 99 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.74303681 |
| 100 | Adherens junction_Homo sapiens_hsa04520 | 0.73974948 |
| 101 | HTLV-I infection_Homo sapiens_hsa05166 | 0.73000949 |
| 102 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.72558631 |
| 103 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.72229302 |
| 104 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.71902810 |
| 105 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.71572157 |
| 106 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.71255899 |
| 107 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.70665445 |
| 108 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.70655532 |
| 109 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.70084701 |
| 110 | Bladder cancer_Homo sapiens_hsa05219 | 0.69893627 |
| 111 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.68825649 |
| 112 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.68645366 |
| 113 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.68135670 |
| 114 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68036469 |
| 115 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.66594964 |
| 116 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.65808137 |
| 117 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64270099 |
| 118 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.63964179 |
| 119 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.62073392 |
| 120 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.61785255 |
| 121 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.59918525 |
| 122 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.59224786 |
| 123 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.58152397 |
| 124 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.57845735 |
| 125 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.57192113 |
| 126 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.57096479 |
| 127 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.55924861 |
| 128 | Cell cycle_Homo sapiens_hsa04110 | 0.55081101 |
| 129 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.52419485 |
| 130 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.51482543 |
| 131 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.50313586 |
| 132 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49972658 |
| 133 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.48692640 |
| 134 | Shigellosis_Homo sapiens_hsa05131 | 0.47871024 |
| 135 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.44830277 |
| 136 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.44327082 |
| 137 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.43810974 |
| 138 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.43019117 |
| 139 | Colorectal cancer_Homo sapiens_hsa05210 | 0.42972755 |
| 140 | Prostate cancer_Homo sapiens_hsa05215 | 0.42958533 |
| 141 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.42876117 |
| 142 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.42763977 |
| 143 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.42375378 |
| 144 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.42269081 |
| 145 | Phagosome_Homo sapiens_hsa04145 | 0.41973437 |
| 146 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.41566092 |
| 147 | Viral myocarditis_Homo sapiens_hsa05416 | 0.40518299 |
| 148 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.40227125 |
| 149 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.38115092 |
| 150 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.35172954 |
| 151 | Hepatitis B_Homo sapiens_hsa05161 | 0.34230929 |
| 152 | Base excision repair_Homo sapiens_hsa03410 | 0.34178777 |
| 153 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.33539836 |
| 154 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.33478368 |
| 155 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.33114495 |
| 156 | Progesterone-mediated oocyte maturation_Homo sapiens_hsa04914 | 0.31881867 |
| 157 | Glioma_Homo sapiens_hsa05214 | 0.31109807 |
| 158 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.30631342 |
| 159 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.30085108 |
| 160 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.29861853 |
| 161 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.29325942 |

